2-iodomelatonin has been researched along with tryptamine in 1 studies
| Studies (2-iodomelatonin) | Trials (2-iodomelatonin) | Recent Studies (post-2010) (2-iodomelatonin) | Studies (tryptamine) | Trials (tryptamine) | Recent Studies (post-2010) (tryptamine) |
|---|---|---|---|---|---|
| 245 | 0 | 10 | 844 | 2 | 221 |
| Protein | Taxonomy | 2-iodomelatonin (IC50) | tryptamine (IC50) |
|---|---|---|---|
| Vif | Human immunodeficiency virus 1 | 1.66 | |
| Tat | Human immunodeficiency virus 1 | 11.753 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burkhardt, S; Dose, A; Hardeland, R; Poeggeler, B; Schoenke, M; Thuermann, S | 1 |
1 other study(ies) available for 2-iodomelatonin and tryptamine
| Article | Year |
|---|---|
Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs.
Topics: 5-Methoxytryptamine; Free Radical Scavengers; Hydroxyl Radical; Melatonin; Molecular Biology; Oxidation-Reduction; Serotonin; Solubility; Structure-Activity Relationship; Superoxides; Tryptamines | 2002 |